PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.65

-1.7%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keta who wrote (6922)	2/5/1999 7:42:00 AM
From: BigKNY3	Read Replies (5) of 9523

Merrill Lynch: Drug approvals in lull, Pfizer a favorite Updated Wed Feb 3, 1999 14:57 GMT By Bridge News New York--Feb 3--Merrill Lynch today released a report on the global pharmaceutical industry saying a "short-term lull in product approvals is underway." The firm predicts a 6% market growth in 1999, which is equal to the growth seen in 1998. * * * Merrill Lynch said the slowdown in approvals should be temporary due to"burgeoning" development pipelines. Pfizer remains one of Merrill Lynch's favorite picks in the sector. Other attractive drug companies include SmithKline Beecham, Warner-Lambert, Johnson &Johnson and Yamanouchi. The firm said its investment strategy continues to focus on companies with strong growth from recently marketed products or those with drugs to be launched in the next 2 years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next